Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2422)
All Articles published online
|
Mar 14, 2007 (publication date) through Jan 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang YQ, Tang XQ, Sun L, Dong L, Qin Y, Liu HQ, Xia H, Cao JG. Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor γ. World J Gastroenterol 2007; 13(10): 1534-1540 [PMID: 17461445 DOI: 10.3748/wjg.v13.i10.1534] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i10/1534.htm |
| Number | Citing Articles |
| 1 |
Hong-Yuan Wang, Ying Zhang, Yue Zhou, Yu-Yin Lu, Wen-Fang Wang, Ming Xin, Xiu-Li Guo. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway. Biomedicine & Pharmacotherapy 2016; 83: 349 doi: 10.1016/j.biopha.2016.06.047
|
| 2 |
YASUHIRO YAMAMOTO, HIROMI KOMA, HIROKI HIRAMATSU, MISA ABE, KAZUNORI MURAKAMI, ASAKO OHYA, TATSUROU YAGAMI. Treatment of etoposide combined with 15-deoxy-Δ12,14-prostaglandin J2 exerted synergistic antitumor effects against renal cell carcinoma via peroxisome proliferator-activated receptor-γ-independent pathways. Molecular and Clinical Oncology 2014; 2(2): 292 doi: 10.3892/mco.2013.234
|
| 3 |
Cristina P. R. Xavier, Cristovao F. Lima, Mikkel Rohde, Cristina Pereira-Wilson. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. Cancer Chemotherapy and Pharmacology 2011; 68(6): 1449 doi: 10.1007/s00280-011-1641-9
|
| 4 |
Xiang-Wen Tan, Hong Xia, Jin-Hua Xu, Jian-Guo Cao. Induction of apoptosis in human liver carcinoma HepG2 cell line by 5-allyl-7-gen-difluoromethylenechrysin. World Journal of Gastroenterology 2009; 15(18): 2234-2239 doi: 10.3748/wjg.15.2234
|
| 5 |
Sandrine Théoleyre, Stéphanie Mottier, Damien Masson, Marc G. Denis. HtrA3 is regulated by 15-deoxy-Δ12,14-prostaglandin J2 independently of PPARγ in clear cell renal cell carcinomas. Biochemical and Biophysical Research Communications 2010; 394(3): 453 doi: 10.1016/j.bbrc.2009.11.163
|
| 6 |
Stephanie K. Bunt, Ashley M. Mohr, Jennifer M. Bailey, Paul M. Grandgenett, Michael A. Hollingsworth. Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer. Cancer Immunology, Immunotherapy 2013; 62(2): 225 doi: 10.1007/s00262-012-1324-3
|
| 7 |
Tamotsu Tsukahara, Shuwa Hanazawa, Tetsuyuki Kobayashi, Yoshiki Iwamoto, Kimiko Murakami-Murofushi. Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator-activated receptor γ. Prostaglandins & Other Lipid Mediators 2010; 93(3-4): 126 doi: 10.1016/j.prostaglandins.2010.09.002
|
| 8 |
Piotr Mrowka, Eliza Glodkowska-Mrowka. PPARγ Agonists in Combination Cancer Therapies. Current Cancer Drug Targets 2020; 20(3): 197 doi: 10.2174/1568009619666191209102015
|
| 9 |
Monica Susan, Ioana Macasoi, Iulia Pinzaru, Cristina Dehelean, Iosif Ilia, Razvan Susan, Ioana Ionita. In Vitro Assessment of the Synergistic Effect of Aspirin and 5-Fluorouracil in Colorectal Adenocarcinoma Cells. Current Oncology 2023; 30(7): 6197 doi: 10.3390/curroncol30070460
|
| 10 |
Jarmila Lauková, Alois Kozubík, Jiřina Hofmanová, Jana Nekvindová, Petr Sova, Mary Pat Moyer, Jiří Ehrmann, Alena Hyršlová Vaculová, Yoshiaki Tsuji. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells. PLOS ONE 2015; 10(10): e0141020 doi: 10.1371/journal.pone.0141020
|
| 11 |
Meng-Fei Lau, Kek-Heng Chua, Vikineswary Sabaratnam, Umah Rani Kuppusamy. Rosiglitazone enhances the apoptotic effect of 5-fluorouracil in colorectal cancer cells with high-glucose-induced glutathione. Science Progress 2020; 103(1) doi: 10.1177/0036850419886448
|
| 12 |
Zhao-Hui Xie, Mei-Fang Quan, Fei Liu, Jian-Guo Cao, Jian-Song Zhang. 5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-322
|
| 13 |
LI-HUA LIU, YING-JUN ZHOU, LAN DING, SHUN-ZHI ZHANG, JI SUN, JIAN-GUO CAO. Induction of apoptosis by VB1 in breast cancer cells: The role of reactive oxygen species and Bcl-2 family proteins. International Journal of Molecular Medicine 2014; 33(2): 423 doi: 10.3892/ijmm.2013.1567
|
| 14 |
Leah Schöckel, Christine Woischke, Sai Agash Surendran, Marlies Michl, Tobias Schiergens, Andreas Hölscher, Florian Glass, Peter Kreissl, Frederick Klauschen, Michael Günther, Steffen Ormanns, Jens Neumann. PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-11985-5
|
| 15 |
Sherif Ashraf Fahmy, Nada K. Sedky, Hatem A. F. M. Hassan, Nour M. Abdel-Kader, Noha Khalil Mahdy, Muhammad Umair Amin, Eduard Preis, Udo Bakowsky. Synergistic Enhancement of Carboplatin Efficacy through pH-Sensitive Nanoparticles Formulated Using Naturally Derived Boswellia Extract for Colorectal Cancer Therapy. Pharmaceutics 2024; 16(10): 1282 doi: 10.3390/pharmaceutics16101282
|
| 16 |
Reza Meshkani, Asie Sadeghi, Gholamreza Taheripak, Maryam Zarghooni, Siavash Gerayesh‐Nejad, Salar Bakhtiyari. Rosiglitazone, a PPARγ agonist, ameliorates palmitate‐induced insulin resistance and apoptosis in skeletal muscle cells. Cell Biochemistry and Function 2014; 32(8): 683 doi: 10.1002/cbf.3072
|
| 17 |
Yun Dai, Liang Qiao, Kwok Wah Chan, Bing Zou, Juan Ma, Hui Y. Lan, Qing Gu, Zesong Li, Yan Wang, Benny L.W. Wong, Benjamin C.Y. Wong. Loss of XIAP sensitizes rosiglitazone‐induced growth inhibition of colon cancer in vivo. International Journal of Cancer 2008; 122(12): 2858 doi: 10.1002/ijc.23443
|
| 18 |
Liang-qi Cao, Xiao-li Wang, Qian Wang, Ping Xue, Xing-yuan Jiao, He-ping Peng, Hai-wu Lu, Qiang Zheng, Xi-lin Chen, Xiao-hui Huang, Xin-hui Fu, Jing-song Chen. Rosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARγ signaling pathway. Acta Pharmacologica Sinica 2009; 30(9): 1316 doi: 10.1038/aps.2009.119
|
| 19 |
Yasuhiro Yamamoto, Megumi Fujita, Hiromi Koma, Motohiro Yamamori, Tsutomu Nakamura, Noboru Okamura, Tatsurou Yagami. 15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways. Biochemical and Biophysical Research Communications 2011; 410(3): 563 doi: 10.1016/j.bbrc.2011.06.026
|
| 20 |
Annika Bundscherer, Christian Hafner. Cancer Microenvironment and Therapeutic Implications. 2009; : 221 doi: 10.1007/978-1-4020-9576-4_12
|
| 21 |
Teodora Costea, Oana Cezara Vlad, Luminita-Claudia Miclea, Constanta Ganea, János Szöllősi, Maria-Magdalena Mocanu. Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer. International Journal of Molecular Sciences 2020; 21(2): 401 doi: 10.3390/ijms21020401
|
| 22 |
Julie Rageul, Stéphanie Mottier, Anne Jarry, Yatrik Shah, Sandrine Théoleyre, Damien Masson, Frank J. Gonzalez, Christian L. Laboisse, Marc G. Denis. KLF4‐dependent, PPARγ‐induced expression of GPA33 in colon cancer cell lines. International Journal of Cancer 2009; 125(12): 2802 doi: 10.1002/ijc.24683
|
| 23 |
Hong-Liang Liang, Qin Ouyang. A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis. World Journal of Gastroenterology 2008; 14(1): 114-119 doi: 10.3748/wjg.14.114
|
| 24 |
Shu-Jun Chiu, Ching-Hui Hsaio, Ho-Hsing Tseng, Yu-Han Su, Wen-Ling Shih, Jeng-Woei Lee, Jennifer Qiu-Yu Chuah. Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells. Biochemical and Biophysical Research Communications 2010; 394(3): 774 doi: 10.1016/j.bbrc.2010.03.068
|
| 25 |
Graham Skelhorne-Gross, Christopher J. B. Nicol. The Key to Unlocking the Chemotherapeutic Potential of PPARγLigands: Having the Right Combination. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/946943
|
| 26 |
Eleonore Fröhlich, Richard Wahl. Chemotherapy and Chemoprevention by Thiazolidinediones. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/845340
|
| 27 |
Geoffrey Girnun. PPARG: A New Independent Marker for Colorectal Cancer Survival. Gastroenterology 2009; 136(4): 1157 doi: 10.1053/j.gastro.2009.02.022
|
| 28 |
Yasuhiro Yamamoto, Hiromi Koma, Tatsurou Yagami. 15-Deoxy-Δ<sup>12,14</sup>-prostaglandin J<sub>2</sub> Inhibits Cell Migration on Renal Cell Carcinoma <i>via</i> Down-Regulation of Focal Adhesion Kinase Signaling. Biological and Pharmaceutical Bulletin 2020; 43(1): 153 doi: 10.1248/bpb.b19-00748
|